4//SEC Filing
ANDO DALE G 4
Accession 0001181431-12-063544
CIK 0001001233other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 8:33 PM ET
Size
7.2 KB
Accession
0001181431-12-063544
Insider Transaction Report
Form 4
ANDO DALE G
VP, Therapeutic Dev. & CMO
Transactions
- Award
Employee Stock Option (Right to Buy)
2012-12-06+70,000→ 70,000 totalExercise: $5.41Exp: 2022-12-05→ Common Stock (70,000 underlying) - Award
Common Stock
2012-12-06+35,000→ 90,798 total
Footnotes (2)
- [F1]Shares subject to Restricted Stock Units, which will vest in a series of three successive equal annual installments upon the Reporting Person's completion of each year of service over the three year period from the grant date.
- [F2]The stock option vests and becomes exercisable for 25% of the shares upon the optionee's completion of one year of service measured from the grant date and vest and become exercisable for the balance of the shares in 36 successive equal monthly installments upon his completion of each additional month of service thereafter.
Documents
Issuer
SANGAMO BIOSCIENCES INC
CIK 0001001233
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001202278
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 8:33 PM ET
- Size
- 7.2 KB